Belvedere Trading
FLNA

Belvedere Trading’s Filana Therapeutics FLNA Stock Holding History

Belvedere Trading’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-70,900
Closed -$167K – 947
2024
Q4 		$167K Sell
70,900
-11,100
-14% -$195K ﹤0.01% 448
2024
Q3 		$2.41M Buy
82,000
+37,200
+83% +$857K ﹤0.01% 79
2024
Q2 		$553K Buy
44,800
+5,700
+15% +$120K ﹤0.01% 171
2024
Q1 		$793K Buy
39,100
+28,200
+259% +$650K ﹤0.01% 107
2023
Q4 		$245K Buy
10,900
+800
+8% +$16.9K ﹤0.01% 292
2023
Q3 		$168K Sell
10,100
-6,200
-38% -$123K ﹤0.01% 249
2023
Q2 		$400K Sell
16,300
-7,300
-31% -$176K ﹤0.01% 175
2023
Q1 		$569K Sell
23,600
-27,800
-54% -$770K ﹤0.01% 128
2022
Q4 		$1.52M Buy
51,400
+47,400
+1,185% +$1.7M ﹤0.01% 45
2022
Q3 		$137K Buy
+4,000
New +$108K ﹤0.01% 168
2021
Q2 		– Sell
-38,800
Closed -$1.74M – 423
2021
Q1 		$1.74M Buy
+38,800
New +$1.53M 0.14% 32

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Belvedere Trading's FLNA Position: Q3 2024 in Review

Belvedere Trading sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 7,855 shares — an estimated $181K sold.

Belvedere Trading first reported a position in FLNA in Q2 2021 and held it in 7 quarters. The position peaked at $1.19M in Q2 2021. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

  • Belvedere Trading reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Belvedere Trading sold 7,855 Filana Therapeutics shares in Q3 2024, an estimated $181K.
  • Belvedere Trading first reported a position in Filana Therapeutics in Q2 2021 and held it in 7 quarters.
  • Belvedere Trading's Filana Therapeutics position peaked at $1.19M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Belvedere Trading's 13F filing for Q3 2024, filed 30 Oct 2024.